{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:50:46Z","timestamp":1761706246731},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T00:00:00Z","timestamp":1233014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s00520-008-0574-2","type":"journal-article","created":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T14:18:20Z","timestamp":1232979500000},"page":"1195-1201","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment"],"prefix":"10.1007","volume":"17","author":[{"given":"Rodney J.","family":"Hunter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makala B.","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine C.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicki F.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles F.","family":"Levenback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Jhingran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark F.","family":"Munsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,27]]},"reference":[{"key":"574_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","volume":"25","author":"H Lager","year":"1999","unstructured":"Lager H, Daugaard G (1999) Cisplatin and hypomagnesemia. Cancer Treat Rev 25:47\u201358, doi: 10.1053\/ctrv.1999.0097","journal-title":"Cancer Treat Rev"},{"key":"574_CR2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0272-6386(86)80020-8","volume":"8","author":"M Lam","year":"1986","unstructured":"Lam M, Adelstein DJ (1986) Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin. Am J Kidney Dis 8:164\u2013169","journal-title":"Am J Kidney Dis"},{"key":"574_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U","volume":"28","author":"G Ariceta","year":"1997","unstructured":"Ariceta G, Rodriguez-Soriano J, Vallo A (1997) Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis. Med Pediatr Oncol 28:35\u201340, doi: 10.1002\/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U","journal-title":"Med Pediatr Oncol"},{"key":"574_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0959-8049(94)00420-A","volume":"31A","author":"TRJ Evans","year":"1995","unstructured":"Evans TRJ, Harper CL (1995) A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5 Fluorouracil. Eur J Cancer 31A:174\u2013178, doi: 10.1016\/0959-8049(94)00420-A","journal-title":"Eur J Cancer"},{"key":"574_CR5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/oxfordjournals.annonc.a057776","volume":"1","author":"PM Netten","year":"1990","unstructured":"Netten PM, de Mulder PHM (1990) Intravenous magnesium supplementation during cisdiammine-dichloroplatinum administration prevents hypomagnesemia. Ann Oncol 1:369\u2013372","journal-title":"Ann Oncol"},{"key":"574_CR6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00000421-199208000-00016","volume":"15","author":"M Martin","year":"1992","unstructured":"Martin M, Diaz-Rubio E (1992) Intravenous and oral magnesium supplementations in the prophylaxis of cisplatinum induced hypomagnesemia. Am J Clin Oncol 15:348\u2013351, doi: 10.1097\/00000421-199208000-00016","journal-title":"Am J Clin Oncol"},{"key":"574_CR7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/bjc.1990.429","volume":"62","author":"EE Vokes","year":"1990","unstructured":"Vokes EE, Mick R (1990) A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin induced hypomagnesemia. Br J Cancer 62:1015\u20131017","journal-title":"Br J Cancer"},{"key":"574_CR8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-90-6-929","volume":"90","author":"RL Schilsky","year":"1979","unstructured":"Schilsky RL, Anderson T (1979) Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin. Ann Intern Med 90:929\u2013931","journal-title":"Ann Intern Med"},{"key":"574_CR9","first-page":"164","volume":"37","author":"G Daugaard","year":"1990","unstructured":"Daugaard G (1990) Cisplatin nephrotoxicity: experimental and clinical studies. Dan Med Bull 37:164\u2013169","journal-title":"Dan Med Bull"},{"key":"574_CR10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","volume":"61","author":"V Launay-Vacher","year":"2008","unstructured":"Launay-Vacher V, Rey JB, Isnard-Bagnis C, Derapy G, Daouphars M (2008) Prevention of cisplatin nephrotoxicity: state of the art and recommendations from European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemother Pharmacol 61:903\u2013909, doi: 10.1007\/s00280-008-0711-0","journal-title":"Cancer Chemother Pharmacol"},{"key":"574_CR11","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanism and renoprotective strategies. Kidney Int 73:994\u20131007, doi: 10.1038\/sj.ki.5002786","journal-title":"Kidney Int"},{"key":"574_CR12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00432-007-0217-x","volume":"133","author":"K Nakazato","year":"2007","unstructured":"Nakazato K, Kim C, Terajima K, Murata S, Fujitani H, Nakanishi K, Tajima H, Kumazaki T, Sakamoto A (2007) Large volume loading to prevent cisplatin-induced nephrotoxicity during negative-balance isolated pelvic perfusion. J Cancer Res Clin Oncol 133:741\u2013747, doi: 10.1007\/s00432-007-0217-x","journal-title":"J Cancer Res Clin Oncol"},{"key":"574_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00280-005-1010-7","volume":"56","author":"H Lajer","year":"2005","unstructured":"Lajer H, Kristensen M, Hansen HH, Nielsen S, Frokiaer J, Ostergaard LF, Christensen S, Daugaard G, Jonassen TE (2005) Magnesium depletion enhances cisplatin-induced nephrotoxicity. Cancer Chemother Pharmacol 56:535\u2013542, doi: 10.1007\/s00280-005-1010-7","journal-title":"Cancer Chemother Pharmacol"},{"key":"574_CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/01926230490508821","volume":"32","author":"AE Vickers","year":"2004","unstructured":"Vickers AE, Rose K, Fisher R, Saulnier M, Sahota P, Bentley P (2004) Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol 32:577\u2013590","journal-title":"Toxicol Pathol"},{"key":"574_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","volume":"25","author":"H Lajer","year":"1999","unstructured":"Lajer H, Daugard G (1999) Cisplatin and hypomagnesemia. Cancer Treat Rev 25:47\u201358, doi: 10.1053\/ctrv.1999.0097","journal-title":"Cancer Treat Rev"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-008-0574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-008-0574-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-008-0574-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:01:51Z","timestamp":1559095311000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-008-0574-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,27]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s00520-008-0574-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,27]]}}}